Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Head of Clinical Strategy at Novartis, Switzerland
Sam is the Head for Clinical Trial Strategy across Translational Medicine in the Novartis Institutes for Biomedical Research, and prior to this was responsible for clinical studies focused on the Musculoskeletal Diseases area. The Translational Medicine group is responsible for studies from first into human, PK/PD studies and patient based Proof-of-Concept studies in various diseases, including those that are rare/orphan and with unmet medical need. The trials led by this group are the first studies in man and then patient, including specific patient populations, and Sam has been involved for over 10 years in the evolution of clinical trial methodology in this area, including considering and adapting to the latest landscape for Novartis.